Oncternal Therapeutics (NASDAQ:ONCT) Coverage Initiated at StockNews.com

StockNews.com assumed coverage on shares of Oncternal Therapeutics (NASDAQ:ONCT – Free Report) in a research note published on Wednesday morning. The firm issued a sell rating on the stock. ONCT has been the topic of a number of other reports. Cantor Fitzgerald reissued a neutral rating and issued a $1.30 target price on shares of […]

Related Keywords

,Oncternal Therapeutics Inc ,Goldman Sachs Group Inc ,Mirabella Financial Services ,Prudential Financial Inc ,Oncternal Therapeutics Company Profile ,Renaissance Technologies ,Richmond Brothers Inc ,Cantor Fitzgerald ,Oncternal Therapeutics ,Free Report ,Therapeutics Trading Down ,Get Free Report ,Sachs Group ,Financial Services ,Orphan Receptor ,Oncternal Therapeutics Daily ,Nasdaq Onct ,Conct ,Medical ,Initiated Coverage ,Stocknews Com ,